Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 43
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01998074 | Evaluation of the Efficacy of a New Formula in Infants With Cow's Milk Protein Allergy | ||
| NCT03688230 | Study of Abituzumab in Combination With Cetuximab and FOLFIRI in Patients With Metastatic Colorectal Cancer. | ||
| NCT02998567 | Combination Study of Guadecitabine/ASTX727 and Pembrolizumab | ||
| NCT05184764 | Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia | ||
| NCT03202303 | Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD) | ||
| NCT02414269 | Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin | ||
| NCT03721068 | Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma | ||
| NCT03047369 | The Myelin Disorders Biorepository Project | ||
| NCT05663710 | Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC | ||
| NCT01940068 | A Double-blind Randomized Controlled Trial of a Thickened Amino-acid-based Formula in Children Allergic to Cow's Milk and to Protein Hydrolysates | ||
| NCT02351531 | Cow Milk Allergy: Evaluation of the Efficacy of a New Thickened Extensively Hydrolyzed Formula in Infants With Confirmed Cow Milk Allergy | ||
| NCT06481280 | Evaluation of Tolerance, Efficacy and Safety of an Hydrolyzed Formula in Infants With IgE/Non-IgE Mediated CMA. | ||
| NCT02710955 | SWAN: Study on the Tolerance and Efficacy of a New Anti-regurgitation Formula (PC-2016-01) | ||
| NCT01070823 | JC-Virus (JCV) Antibody Program | ||
| NCT02425423 | Study on the Tolerance and Efficacy of a New Anti Regurgitation Formula | ||
| NCT02733614 | Proof-of-concept Study to Assess the Efficacy and Safety of SRX246 in Adults With PTSD | ||
| NCT00973908 | Probiotics for the Prevention of Antibiotics Associated Diarrhoea and Clostridium Difficile Associated Diarrhoea | ||
| NCT05340712 | Evaluation of the Efficacy of a New Specific Infant Formula in Case of Functional Constipation | ||
| NCT04358146 | Study on the Efficacy and Tolerance of a New Anti-regurgitation Infant Formula (STELLAR) | ||
| NCT04989946 | Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer | ||
| NCT03880487 | A Single and Multiple Ascending Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of KP-1199 | ||
| NCT02711163 | Evaluation of the Hypoallergenicity of an Extensively Hydrolyzed Formula | ||
| NCT06636786 | Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL) | ||
| NCT02008877 | SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors) | ||
| NCT05337124 | A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US | ||
| NCT00262106 | Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection | ||
| NCT05318300 | Evaluation of an Adapted Formula on Atopic Dermatitis. | ||
| NCT05620342 | Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer | ||
| NCT00860470 | Antenatal Micronutrient Supplementation and Infant Survival | ||
| NCT05082259 | ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab | ||
| NCT02455024 | An Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With ICLUSIG® | ||
| NCT06613217 | Study of Oral PCLX-001 in R/R Acute Myeloid Leukemia | ||
| NCT01122641 | The Vascular Effects of Vildagliptin in Insulin Resistant Individuals | ||
| NCT06488274 | Evolution of Functional Gastrointestinal Disorders in Infants Fed With a New Infant Formula | ||
| NCT01326481 | Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast Cancer | ||
| NCT00578240 | Molecular Studies and Clinical Correlations in Human Prostatic Disease | ||
| NCT02058680 | Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent Patients | ||
| NCT01985607 | Efficacy of a New Thickened Extensively Hydrolyzed Formula | ||
| NCT00069511 | 12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy. | ||
| NCT02796885 | Characterisation of Adult-Onset Hypophosphatasia | ||
| NCT01661283 | SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors | ||
| NCT03557671 | Evaluation of the Hypoallergenicity of a New Formula Based on Hydrolyzed Rice Proteins | ||
| NCT02216383 | Intramuscular Oxytocics: A Randomised Control Trial |
